SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Legal Advantage Investments Inc.

Legal Advantage Investments Inc. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,965 shares of the exchange traded fund’s stock after selling 600 shares during the period. Legal Advantage Investments Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,798,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $141,284,000. Northwestern Mutual Wealth Management Co. raised its position in shares of SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after purchasing an additional 18,202 shares during the last quarter. Mirae Asset Securities USA Inc. raised its position in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter. Finally, Employees Retirement System of Texas raised its position in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.1 %

Shares of NYSEARCA XBI opened at $87.97 on Tuesday. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market cap of $6.71 billion, a PE ratio of 11.47 and a beta of 1.11. The company has a 50-day moving average of $93.78 and a 200 day moving average of $96.96.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.